Zoledronic Acid Injection
Product Images NDC 68001-437

4 FDA label images from Bluepoint Laboratories · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 68001-437). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zoledronic Acid Injection Carton (Zoledronic Acid Carton)

Zoledronic Acid Injection Carton (Zoledronic Acid Carton)
Packaging label for Zoledronic acid Injection 4 mg/5 mL (0.8 mg/mL) by BluePoint Laboratories. The label includes dosage form as an intravenous injection, usage instructions emphasizing dilution and single-use vial, storage conditions, and manufacturing details from India. The label shows NDC 68001-437-25 and features barcodes and warnings for proper handling.*
FDA Label Image

Zoledronic Acid Structural Formula (Zoledronic Acid Chemical Structure)

Zoledronic Acid Structural Formula (Zoledronic Acid Chemical Structure)
Chemical structure of zoledronic acid showing a bicyclic ring system attached to a side chain with two phosphonic acid groups and one hydroxyl group.*
FDA Label Image

Zoledronic Acid Injection Label (Zoledronic Acid Container)

Zoledronic Acid Injection Label (Zoledronic Acid Container)
Label for Zoledronic acid Injection 4 mg/5 mL (0.8 mg/mL) single-dose vial. It is an intravenous infusion product by BluePoint Laboratories. The label includes dosage form, strength, route, storage instructions, manufacturer details, and a barcode. The vial size is 5 mL, and the product is Rx only.*
FDA Label Image

Figure 1 Proportion Of Complete Responders By Day 10 In Pooled Hcm Studies (Zoledronic Acid Figure 1)

Figure 1 Proportion Of Complete Responders By Day 10 In Pooled Hcm Studies (Zoledronic Acid Figure 1)
A bar chart comparing the proportion of complete responders by day 10 in pooled HCM studies between Zoledronic Acid Injection 4 mg (n=86) and Pamidronate 90 mg (n=99). The chart shows a higher percentage of complete responders for Zoledronic Acid versus Pamidronate, with a P-value of 0.002 indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.